Caricamento...
Successful treatment of Takayasu arteritis with rituximab as a first-line immunosuppressant
Takayasu arteritis is a rare large vessel vasculitis which has traditionally been treated with high-dose steroids. There have been a small number of publications where biological agents have been used to manage refractory cases. To the authors knowledge, there are no publications using biological ag...
Salvato in:
| Pubblicato in: | BMJ Case Rep |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Publishing Group
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5256557/ https://ncbi.nlm.nih.gov/pubmed/28073870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2016-217313 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|